Pieris Pharmaceuticals Price on September 25, 2024
PIRSDelisted Stock | USD 13.60 1.41 9.39% |
If you're considering investing in Pieris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pieris Pharmaceuticals stands at 13.60, as last reported on the 28th of December, with the highest price reaching 15.35 and the lowest price hitting 13.26 during the day. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Pieris Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pieris Pharmaceuticals' Coefficient Of Variation of (911.59), risk adjusted performance of (0.08), and Variance of 7.53 to confirm the risk estimate we provide.
Pieris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pieris |
Sharpe Ratio = -0.113
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PIRS |
Estimated Market Risk
2.82 actual daily | 25 75% of assets are more volatile |
Expected Return
-0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pieris Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pieris Pharmaceuticals by adding Pieris Pharmaceuticals to a well-diversified portfolio.
Pieris Pharmaceuticals Valuation on September 25, 2024
It is possible to determine the worth of Pieris Pharmaceuticals on a given historical date. On September 25, 2024 Pieris was worth 17.06 at the beginning of the trading date compared to the closed value of 16.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pieris Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Pieris Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pieris Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pieris Pharmaceuticals' related companies.
Open | High | Low | Close | Volume | |
16.83 | 17.23 | 16.83 | 17.07 | 1,572 | |
09/25/2024 | 17.06 | 17.20 | 16.46 | 16.49 | 6,801 |
16.60 | 17.00 | 16.16 | 16.16 | 8,323 |
Backtest Pieris Pharmaceuticals | | | Pieris Pharmaceuticals History | | | Pieris Pharmaceuticals Valuation | Previous | Next |
Pieris Pharmaceuticals Trading Date Momentum on September 25, 2024
On September 26 2024 Pieris Pharmaceuticals was traded for 16.16 at the closing time. The top price for the day was 17.00 and the lowest listed price was 16.16 . The trading volume for the day was 8.3 K. The trading history from September 26, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.00% . The trading delta at closing time against the current closing price is 1.88% . |
Pieris Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Pieris Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pieris Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pieris financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pieris Pharmaceuticals Stock history
Pieris Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pieris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pieris Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pieris Pharmaceuticals stock prices may prove useful in developing a viable investing in Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.
Pieris Pharmaceuticals Stock Technical Analysis
Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Pieris Pharmaceuticals Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Pieris Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pieris Pharmaceuticals December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Pieris Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pieris Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pieris Pharmaceuticals stock market strength indicators, traders can identify Pieris Pharmaceuticals entry and exit signals to maximize returns
Pieris Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pieris Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pieris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pieris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.31) | |||
Total Risk Alpha | (0.39) | |||
Treynor Ratio | 5.04 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Pieris Stock
If you are still planning to invest in Pieris Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pieris Pharmaceuticals' history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |